Skip to main content

Incannex welcomes world-leading psychedelics experts to advisory board

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Incannex Healthcare Ltd (ASX:IHL, NASDAQ: IXHL) director Peter Widdows tells Proactive the company has appointed three world-renowned psychedelic therapy and science experts to its Clarion Clinics Group Advisory Board. The Clarion Clinics Groups Pty Ltd is a collaborative venture between Incannex and three leading Australian psychedelics experts - Dr Paul Liknaitzky, Professor Suresh Sundram and Sean O’Carroll.

Contact Details

Proactive Investors

Jonathan Jackson

+61 413 713 744

Jonathan@proactiveinvestors.com

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  246.21
+5.86 (2.44%)
AAPL  338.00
-6.63 (-1.92%)
AMD  467.61
-37.19 (-7.37%)
BAC  49.68
-0.33 (-0.67%)
GOOG  279.35
+1.13 (0.41%)
META  608.22
-6.77 (-1.10%)
MSFT  508.17
-13.74 (-2.63%)
NVDA  201.98
-2.66 (-1.30%)
ORCL  118.81
-11.86 (-9.08%)
TSLA  401.67
+1.86 (0.46%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.